Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
Japan
· Delayed Price · Currency is JPY 1,411.00
-20.00 (-1.40%)
Apr 2, 2025, 2:44 PM JST
TYO:2395 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 30,701 | 26,450 | 25,090 | 17,748 | 15,110 | 14,561 | Upgrade
|
| Revenue Growth (YoY) | 14.97% | 5.42% | 41.37% | 17.46% | 3.77% | -7.01% | Upgrade
|
| Cost of Revenue | 15,606 | 12,168 | 12,044 | 8,061 | 7,557 | 6,945 | Upgrade
|
| Gross Profit | 15,095 | 14,282 | 13,046 | 9,687 | 7,553 | 7,616 | Upgrade
|
| Selling, General & Admin | 11,311 | 8,116 | 6,830 | 4,908 | 4,482 | 4,840 | Upgrade
|
| Research & Development | - | 1,741 | 683 | 425 | 392 | 400 | Upgrade
|
| Operating Expenses | 11,575 | 10,120 | 7,801 | 5,491 | 5,024 | 5,387 | Upgrade
|
| Operating Income | 3,521 | 4,162 | 5,245 | 4,196 | 2,529 | 2,229 | Upgrade
|
| Interest Expense | -190.13 | -138 | -125 | -126 | -184 | -235 | Upgrade
|
| Interest & Investment Income | 149.16 | 188 | 58 | 8 | 2 | 9 | Upgrade
|
| Earnings From Equity Investments | 3,232 | 2,751 | 2,489 | 1,439 | 846 | 888 | Upgrade
|
| Currency Exchange Gain (Loss) | -599.83 | 60 | 1,511 | 1,370 | 239 | -233 | Upgrade
|
| Other Non Operating Income (Expenses) | 158 | -7 | 16 | 190 | 211 | 461 | Upgrade
|
| EBT Excluding Unusual Items | 6,270 | 7,016 | 9,194 | 7,077 | 3,643 | 3,119 | Upgrade
|
| Gain (Loss) on Sale of Investments | -9.44 | 51 | -1,327 | 1,381 | 1,173 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -47.88 | -50 | -13 | -21 | -4 | 1 | Upgrade
|
| Asset Writedown | -139.16 | -34 | -44 | -225 | -639 | -58 | Upgrade
|
| Other Unusual Items | -7.87 | -9 | -51 | -30 | - | -1 | Upgrade
|
| Pretax Income | 6,066 | 6,974 | 7,759 | 8,182 | 4,173 | 3,061 | Upgrade
|
| Income Tax Expense | 1,177 | 1,456 | 1,708 | 1,016 | 497 | 414 | Upgrade
|
| Earnings From Continuing Operations | 4,889 | 5,518 | 6,051 | 7,166 | 3,676 | 2,647 | Upgrade
|
| Minority Interest in Earnings | 53.07 | 13 | 9 | -39 | -15 | -97 | Upgrade
|
| Net Income | 4,942 | 5,531 | 6,060 | 7,127 | 3,661 | 2,550 | Upgrade
|
| Net Income to Common | 4,942 | 5,531 | 6,060 | 7,127 | 3,661 | 2,550 | Upgrade
|
| Net Income Growth | -10.19% | -8.73% | -14.97% | 94.67% | 43.57% | 30.77% | Upgrade
|
| Shares Outstanding (Basic) | 42 | 42 | 42 | 42 | 42 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 42 | 42 | 42 | 42 | 42 | 42 | Upgrade
|
| Shares Change (YoY) | 0.00% | - | -0.00% | - | - | - | Upgrade
|
| EPS (Basic) | 118.71 | 132.86 | 145.56 | 171.19 | 87.94 | 61.25 | Upgrade
|
| EPS (Diluted) | 118.71 | 132.86 | 145.56 | 171.19 | 87.94 | 61.25 | Upgrade
|
| EPS Growth | -10.19% | -8.73% | -14.97% | 94.67% | 43.57% | 30.77% | Upgrade
|
| Free Cash Flow | - | -6,476 | -834 | 4,410 | 3,679 | 1,870 | Upgrade
|
| Free Cash Flow Per Share | - | -155.56 | -20.03 | 105.93 | 88.37 | 44.92 | Upgrade
|
| Dividend Per Share | 50.000 | 50.000 | 50.000 | 30.000 | 10.000 | 5.000 | Upgrade
|
| Dividend Growth | - | - | 66.67% | 200.00% | 100.00% | 66.67% | Upgrade
|
| Gross Margin | 49.17% | 54.00% | 52.00% | 54.58% | 49.99% | 52.30% | Upgrade
|
| Operating Margin | 11.47% | 15.73% | 20.91% | 23.64% | 16.74% | 15.31% | Upgrade
|
| Profit Margin | 16.10% | 20.91% | 24.15% | 40.16% | 24.23% | 17.51% | Upgrade
|
| Free Cash Flow Margin | - | -24.48% | -3.32% | 24.85% | 24.35% | 12.84% | Upgrade
|
| EBITDA | 5,589 | 6,029 | 6,845 | 5,373 | 3,716 | 3,458 | Upgrade
|
| EBITDA Margin | 18.20% | 22.79% | 27.28% | 30.27% | 24.59% | 23.75% | Upgrade
|
| D&A For EBITDA | 2,069 | 1,867 | 1,600 | 1,177 | 1,187 | 1,229 | Upgrade
|
| EBIT | 3,521 | 4,162 | 5,245 | 4,196 | 2,529 | 2,229 | Upgrade
|
| EBIT Margin | 11.47% | 15.73% | 20.91% | 23.64% | 16.74% | 15.31% | Upgrade
|
| Effective Tax Rate | 19.40% | 20.88% | 22.01% | 12.42% | 11.91% | 13.53% | Upgrade
|
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.